Wikipedia has a list of repurposed drugs, a bit outdated.
Pretty much all of the monoclonal antibodies are no longer useful. The virus just mutates to avoid them. 🙁
These are now part of standard care for vulnerable (e.g. elderly) non-hospitalized patients:
- Pfizer’s Paxlovid, a combination of two protease inhibitors (nirmatrelvir and ritonavir) is 89% effective against severe disease. Probably will cost ~US$500 per treatment course. It was approved for emergency use in the EU on 2021-12-16, in the USA on 2021-12-22, and in Canada on 2022-01-17. There is anecdata that Paxlovid cures Long COVID, for example this case report.
- Marck’s molnupiravir (trade name Lagevrio) is 30% effective against severe disease (originally it was 50%, but I guess they redid their calculations or something). It works by mutating the virus to death. Approved 4 November by the UK. Probably will cost ~US$700 per treatment course.
These are now part of standard care for hospitalized patients:
- Dexamethasone, 17% mortality reduction.
- Remdesivir (AKA Veklury), injected. There was some controversy about its effectiveness, especially given its cost, but a more recent study found it cut the chance of going on a ventilator by half.
These are good:
- IL-6 blockers, 24% mortality reduction on top of dexamethasone
- Oral therapies:
- Metformin:
- This paper from USA (2024-09-17) reports that, compared to people taking other diabetes medications, people taking metformin had ~15% lower risk of Long COVID or death.
- This paper from USA (2024-05-25) suggests that metformin might be even better for women than for me.
- This paper from USA (2024-05-01) found that people who took metformin were 28% less likely to detectable viral load than placebo at day 5 or 10, and 32% less likely to have viral rebound than people who took a placebo.
- This paper from USA (2024-06-08) reports that COVID-positive overweight or obese (but not diabetic) patients were 41% less likely to get Long COVID than people who got a placebo.
- This preprint from the USA (2023-06-07) says that metformin reduced the COVID-19 viral load by 3.6x over placebo.
- This paper from the USA (2022-12-24) says that metformin reduces Long COVID by almost half.
- This paper from USA (2022-11-17) reports that people with Type 2 diabetes were 18% less likely to die if they took metformin compared to those who took dipeptidyl-peptidase-4-inhibitors and 64% less likely to die compared to those who took sulfonylureas.
- This paper from USA (2022-11-14) reports that
- prediabetics who took metformin had a 37% lower risk of mild COVID-19 and a 82% lower risk of severe COVID-19 than those who took levothyroxine;
- prediabetics who took metformin had a 96% lower risk of mild COVID-19 and a 81% lower risk of severe COVID-19 than those who took ondansetron;
- people with polycystic ovary syndrome (POS) who took metformin had the same COVID-19 risks as those who took levothyroxine;
- people with POS who took metformin had a 90% lower risk of mild COVID-19 and a 99% lower risk of severe COVID-19 than those who took ondansetron.
- This paper from the USA (2022-08-18) says that metformin reduces the chance of at least one of death, hospitalization, emergency visits, and hypoxemia by 16%.
- This paper from USA (2021-01-12) reports that diabetics who were taking metformin before getting COVID-19 infections were 67% less likely to die than those who were not.
- This paper from the USA (2020-12-03) found that obese or diabetic women hospitalized for COVID-19 were 22% less likely to die if they took metformin than if they did not. (Curiously, there was no benefit for men.)
- Ensitrelvir (brand name Xocova, approved in Japan for emergency use on 2022-11-22, full approval on 2024-03-05):
- This paper (2024-02-09) found that patients who took ensitrelvir recovered about a day faster than those who did not.
- This 2023-02-22 press release reports that patients who took Ensitrelvir Fumaric Acid took 80% less time to test negative.
- 2023-07-13 preprint: Patients who took ensitrelvir got better about 24 hrs faster than those who didn’t.
- There are quite a few papers now that say that the gut biome is messed up by COVID-19. Some explicitly say that probiotics help. This Twitter thread has more (if Twitter is still alive), but here’s a list:
- 2022-09-28 paper: hospitalized patients who took a probiotic containing the K12 strain of S. salivarius were 3.4 times less likely to die than controls.
- 2021-08-15 Letter to Editor: None of 33 Italian schoolchildren taking S. salivarius K12 supplements got COVID-19, while 24 of 46 (52%) of the controls did.
- S. Salivarius is available online in some countries, e.g. BioNAZE in the US.
- See this Twitter thread for someone else’s summary of probiotics.
- antihistamines:
- 20240702 paper from China: They found that a variety of H1 antagonists did a good job of blocking COVID-19 from entering cells in test tubes and mice with human immune systems. (They tested it as a prophylactic, but if they are correct about the mechanism, it also should be a good treatment.)
- 2021-01-25 paper from Spain: 0% of nursing home residents at a specific nursing home who got COVID-19 (which was all of them!) treated with H1 antagonists died, while peer nursing homes had a 28% fatality rate.
- There was some excitement early in the pandemic about H2 antagonists — electronic record data seemed to indicate that famotidine helped against COVID — but later research seems to say that H2 agonists weren’t helpful.
- This case study (2022-02-07) reports on two women with bad Long COVID who got ~90% of function back after starting to take daily H1 antagonist antihistamines.
- This paper (2023-02-07) gives a bit of theory (but no hard data) on why antihistamines might be good.
- Metformin:
- Nasal therapies (also useful as a prophylactic sometimes):
- Sinus irrigation (aka “neti pot”)
- 20231108 This paper from USA says that people who gargled and irrigated their nose with saline had ~1/3 the hospitalization rate of controls.
- 20220825 This preprint says that nasal irrigation of good old saline is quite effective at reducing the severity of COVID-19. (The effectiveness that the article gives says that it’s more effective than Paxlovid!)
- This paper says symptoms resolved 4-7 days earlier for people who irrigated with saline.
- This paper from right before the pandemic says that people with the common cold (note: many colds are from non-COVID-19 coronaviruses) who irrigated with saline resolved symptoms about two days earlier than those who did not, and their household transmission was 35% lower than for controls. Looking at the graphs of symptoms over time for each group, it looks to me like the difference is mostly in eliminating long-duration outliers.
- SaNOtize (AKA Enovid, VirX) (Nitric Oxide):
- Spring 2023 This paper from Thailand reports that 6.40% of students who took Enovid got COVID-19, compared to 25.59% in the control group.
- The nasal spray SaNOtize was approved in India on 10 Feb 2022, manufactured under the name VirX (now FabiSpray).
- 20220629 This paper from India found that patients using Enovid 6x daily cleared their infection four days faster than patients using placebo.
- 20210513 This paper from UK found that the viral load dropped 95% a day after using Enovid 5-6x per day.
- SaNOtize/VirX is available now in India (as FabiSpray), Israel and Bahrain (as Enovid), and Thailand, Singapore, Hong Kong, Nepal, South Africa, Germany.
- Viraleze, which according to the company website on 20231025 is available in UK, Europe, Southeast Asia, South Africa, Australia, and New Zealand:
- 20221005 This paper says that in a randomized controlled trial, COVITRAP increased the inhibitory effects in nasal fluids.
- 20210409 This paper from the UK says that people infected with COVID-19 who inhaled budesonide (a corticosteroid) twice per day early in the infection had less severe illness and recovered about one day faster.
- 20221022 This paper says that in a randomized controlled trial in healthcare workers, people who used pHOXBIO nasal spray 62% fewer infections than controls.
- 20211001 This paper from Argentina reports that Iota-Carrageenan gave a relative risk reduction of catching COVID-19 of about 80% when used four times per day.
- I don’t have links to research backing it the claims, but Covixyl claims to help prevent COVID-19 and Betadine Cold Defense Nasal Spray claims to help prevent colds.
- 20190131: This prepandemic paper from UK found that people who irrigated sinuses and gargled with saline solution recovered from upper respiratory infections 1.9 days faster than those who did not and reduced household transmission by 35%.
- 20210409 This paper from the UK says that people infected with COVID-19 who inhaled budesonide (a corticosteroid) twice per day early in the infection had less severe illness and recovered about one day faster.
- 20210823 Paper showing 22% lower risk in people who were already taking intranasal corticosteroids.
- Sinus irrigation (aka “neti pot”)
- Mouthwashes: I was sceptical that mouthwashes might help reduce transmission or disease severity because killing viruses in the mouth doesn’t get rid of virus in the nose, lungs, gut, or other organs. HOWEVER, there is some evidence that it does help:
- 2022-06-21 This paper from Spain reports that the saliva of people who gargled with a 0.07% cetylpyridinium chloride (CPC) mouthwash showed a significant increase in proteins from the SARS-CoV-2 nucleocapsid compared to placebo. (Translation: the CPC ripped the SARS-CoV-2 to shreds, leaving lots of pieces of the interior of the SARS-CoV-2 virus in people’s saliva.)
- 2022-03-05: This paper says that in a clinic where patients rinsed with dilute hydrogen peroxide once they entered a treatment room, they found virus in the waiting room’s filter but not in the treatment rooms’ filters.
- 2002-04-27: This prepandemic paper found that Japanese schoolchildren who gargled with Povidone-Iodine had an absentee rate of 19.8% for upper respiratory infections compared to 25.5% in schools where the students did not gargle.
- 2005-10-19: This prepandemic paper from Japan found that people who gargled with povidone/iodine had an 11% lower risk of getting an upper respiratory disease than controls. Interestingly, people who gargled with tap water had a 36% lower risk than controls! (Maybe this is due to the tap water in the study’s city being heavily chlorinated? I saw something about that in a different paper from Japan.)
- 2002-04-27: This prepandemic paper from Japan found that adults who had histories of ongoing problems with repeated upper respiratory infections decreased their infection frequency dramatically after gargling with povidone/iodine regularly (4x/day).
- For which solution to rinse with:
- 20210301: This paper measured the effects of various mouthwashes and concluded that hydrogen peroxide (Colgate Peroxyl) was best at killing COVID-19 in the mouth, followed by povidone-iodine, chlorhexidine gluconate (CHG), and Listerine (essential oils and alcohol).
- This paper (20230703) and this paper (20201210) say povidone iodine gargle reduces viral load in the mouth.
- 20200815 This review article discusses mouthwashes and viral loads in the mouth, but was kind of wishy-washy about relative merits of different mouthwashes. Same with this review article (20200905).
- 20210707: This paper found that there wasn’t much difference between Chlorhexidine 0.2% and 1% Povidone-iodine solutions.
- Eye drops
- 20201124 This article says that eye drops Lumify and Besivance got rid of COVID-19 in the eye. That probably isn’t going to help you avoid getting COVID-19 any better than a pair of glasses, but maybe? it will help COVID-related conjunctivitis?
There are quite a few papers now that say that the gut biome is messed up by COVID-19. Some explicitly say that probiotics help. See this Twitter thread for a summary.
In the pipeline:
- Preliminary results for Novartis’ Ensovibep say that it’s 78% effective at preventing hospitalization. This article says it works against BA.1.
Baricitinib reduces deaths by 13% on top of whatever other benefit patients are getting from other drugs (3 March 2022).- Sabizabulin reduces deaths among hospitalized patients from 50% to 20%, according to the manufacturer. On 20230302, the US FDA declined to give it an emergency use authorization, but that was mostly due to concerns about the study size being too small; I had the impression that it will probably turn out to be a good drug.
- A cheap liver drug called UDCA might help, but it’s speculative.
- peginterferon lambda — which this 20230209 study says cuts the risk of severe infection by 50%.
- Paper on small trial effectiveness of 35B5 monoclonal antibody.
- Intranasal:
- 20230323 This paper from Finland says an Intranasal trimeric sherpabody called TriSb92 protected mice from infection.
- 20230123 This paper from Thailand found that a spray which contained a turmeric extract did a good job in test tubes at killing off COVID-19.
- Intranasal photodynamic therapy
This paper says that glycine supplements help defend against viruses in general.
Potentially effective?
- sarilumab
- inhaled budesonide — one study says that it reduces hospitalization, fever, recovery period
- amodiaquine (an antimalarial) shows good results in hamsters
- ADG20, a monoclonal antibody
- Ciclesonide
- Vitamin D looked good, then it didn’t, and now here’s a press release saying it is useful.
- 20231025 This paper found that people who got simvastatin — a statin — were 12% more likely to survive a serious COVID-19 infection. However, this was not enough to meet the prespecified criteria for superiority to controls.
These used to be good:
Long COVID
Prevention
These treatments have been shown to reduce the incidence of Long COVID:
- Vaccination cuts the risk of Long COVID by 15-40%
- 2024-01-16 paper from USA found that the vaccine effectiveness was 35.4% against probable (symptom-based) Long COVID and 41.7% against diagnosed Long COVID in children.
- 2024-01-11 paper from Spain
- 20221128 paper from USA: Rheumatology patients had 50% lower risk of Long COVID.
- 20210901 paper from UK
- March 2022 review article from UK using electronic data records from really huge datasets from UK (2 datasets), Spain, and Estonia found VE of ~50-70% against Long COVID compared to unvaxxed.
- 20230228 review article from Australia.
- 20230228 paper from France: 16.6% v 7.5% risk.
- 20220702 paper from Italy ~40%
- 20220525 from US: ~15% (Veteran’s Affairs, so mostly of old white men)
- Metaformin cuts the risk of Long COVID by about 40%.
- Paxlovid
- 2022-11-05 preprint from USA: cuts risk by about 25%
- 20230222 press release claiming that ensitrelvir fumaric acid/ensitrelvir/Xocova reduces Long COVID risk by 45%. Currently being used in Japan (article 20221207).
Long COVID Treatments
- Antihistamines:
- This case study (2022-02-07) reports on two women with bad Long COVID who got ~90% of function back after starting to take daily H1 antagonist antihistamines.
- 20230716 paper from Italy: fexofenadine (an H1 agonist) + famotidine (an H2 agonist) completely resolved the symptoms of 25% of the long haulers.
- 20230614 paper from Iran: famotidine (an H2 agonist) reduced cognitive issues in Long COVID patients.
- Stellate ganglion block (anesthetizing a branch of the vagus nerve) restores taste and smell in many people:
- 2024-09-19 blog post from a caretaker of a severely disabled Long COVID patient (PhysicsGirl) saying that a stellate ganglion block, she — while still profoundly disabled — had improved energy, cognition, and could tolerate more foods.
- 2023-11-20 presentation saying that 82% of people regained smell and/or taste in one month or less after getting a stellate ganglion block.
- 2023-01-31 article on a clinic in Texas treating loss of smell.
- 2022-01-15 case study (2 patients).
- 2022-08-14 case study (1 patient).
- 2023-0405 mass media article about one woman who had smell restored in December 2022 with a stellate ganglion block.
- Nicotine
- 2023-01-18 case study (4 patients) found that four Long COVID patients who wore nicotine patches for up to seven days recovered completely in 24 days or less.
- Here’s a long lay article on using nicotine patches which mentions a self-medicator-led survey which found that 20% of long haulers felt more than 50% better, 36% felt 0-50% better, 20% felt the same, 5% felt worse, and 17% were still checking it out.
- If you want to try self-dosing with nicotine patches, please check out the Renegade Researchers/The Nicotine Test Facebook group and/or web page for self-medicators. In particular, do NOT cut the patches! Some patches will release all of the nicotine at once if you cut them, and it’ll make you sick. Instead, block an area of the patch.
- Here’s one self-medicator’s notes, with hypothesis, his experience, and notes on exactly how he self-dosed with nicotine.
- 2023-11-08 case study (3 patients) found that monoclonal antibody infusions made them better.
- BC007 (Berlin Cures is trying to bring it to market):
- This paper from Serbia (2024-04-30) found that a creatine-glucose supplement for eight weeks decreased severl symptoms in long haulers.
- Vaccination:
- 20230915 paper from Canada found that Long COVID patients symptom count dropped from 6.56 to 3.92 after vaccination.
- 20230228 paper from Japan: About half of the unvaccinated people who had Long COVID got better after an mRNA vaccination.
- Guanfacine (an ADHD drug) plus N-acetylcysteine (an anti-oxidant used to treat traumatic brain injury) for brain fog:
- Low-dose Naltrexone (LDN):
- 20240123 paper from USA: People who took low-dose Naltrexone were about five times as likely to see improvement in their pain and fatigue symptoms than people who only did physical therapy. People taking amitriptyline saw improvement in pain but not fatigue.
- 20220703 paper from Ireland: in a small study, taking LDN gave statistically significant improvements.
- 20230113 Review article with a section on treatments.
In Galen’s Long Covid Survival Guide, a guy tells what worked (partially) for him with Long COVID. tl;dr: antihistamine, low-dose Naltrexone, nicotine patches, antibiotic Amox-Clav, probiotic, better nutrition, liposomal Glutathione supplement, Melatonin.
Advice
This page has a big section on what to do if you get COVID-19.
Not Effective
- This paper (20221215) found that gabapentin was effective at restoring smell, but this random controlled trial (20230921) found that it was not. The first paper was smaller and did not have controls, so I trust the second.
- @@@TBD@@@ list all the monoclonal antibodies which don’t work any more against acute COVID-19